Invesaro

Stocks Health care PRFX

NASDAQ · Health care

PRF Technologies Ltd. (PRFX)

PRF Technologies Ltd. reported revenue of $17K in fiscal 2025. It posted a net loss of $5M. In fiscal 2025 capital spending exceeded operating cash flow by $4M. At December 31, 2025 it held $3.1M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 26, 2026.

Free, no password. An email when PRFX files with the SEC.

Price
$0.74
-7.12% on the day · November 11, 2026
52-week range $0.64 to $7.95
Market cap
$2.3M
Revenue (FY2025)
$17K
Net margin
-29,541.2%

Key facts about PRF Technologies Ltd.

Net worth
PRF Technologies Ltd. has a market value (market cap) of $2.3M at the latest share price, and shareholders' equity of $8.5M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $17K, with a net loss of $5M.
Cash flow
In fiscal 2025 operations used $4M of cash.
Latest report
The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on March 26, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR

What PRF Technologies Ltd. does

PRF Technologies Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PRFX.

Revenue and profit by year

Revenue
FY23: $0 $0 FY23FY24: $0 $0 FY24FY25: $17K $17K FY25
Net income
FY18: -$828K -$828K FY18FY20: -$1.3M -$1.3M FY20FY20: -$4.1M -$4.1M FY20FY21: -$7.2M -$7.2M FY21FY22: -$8.8M -$8.8M FY22FY23: -$9.3M -$9.3M FY23FY24: -$14.6M -$14.6M FY24FY25: -$5M -$5M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$17K-$5.1M-$5M-$7.47-$4M
2024$0-$14.7M-$14.6M-$105.52-$12.6M
2023$0-$9.6M-$9.3M-$122.94-$6.7M
2022n/a-$8.9M-$8.8M-$123.58-$6.5M
2021n/a-$7.2M-$7.2M-$110.21-$6.6M
2020n/a-$1.7M-$4.1M-$186.16-$2.6M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Where PRFX ranks in Health care

Revenue$17K
#738 of 751 in Health care · Bottom 2%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What PRF Technologies Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 28, 2026
  2. September 24, 2026
  3. September 16, 2026
  4. September 9, 2026
  5. September 3, 2026
  6. September 3, 2026
  7. July 27, 2026
  8. July 21, 2026
  9. July 15, 2026
  10. July 8, 2026

Recent insider filings (Forms 3, 4 and 144): 7, the latest on March 18, 2026. Insider transactions on SEC

Insider trades

What the people running PRF Technologies Ltd. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns PRFX

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
YA II PN, Ltd.13G, passive with 7 related filers 9.99% 333,105 June 22, 2026
S.H.N. Financial Investments Ltd.13D, may seek influence 5.72% 200,000 September 24, 2026

Latest filings below 5%: Blade Ranger Ltd. 0% (June 16, 2026).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

No insider reported holdings on a Form 4 in the last 12 months.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about PRFX

What does PRF Technologies Ltd. do?

PRF Technologies Ltd. is a company in the Health care sector, listed on NASDAQ as PRFX. Its shares trade on NASDAQ under the ticker PRFX.

What is PRF Technologies Ltd.'s net worth?

PRF Technologies Ltd. has a market value (market cap) of $2.3M at the latest share price, and shareholders' equity of $8.5M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is PRF Technologies Ltd. profitable?

No. In fiscal 2025 it reported a net loss of $5M on revenue of $17K.

How much revenue does PRF Technologies Ltd. make?

In fiscal 2025 PRF Technologies Ltd. reported revenue of $17K.

When did PRF Technologies Ltd. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 26, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 28, 2026.

Similar companies

Compare PRFX with

Compare PRFX with any company

Follow PRFX

Get an email when PRF Technologies Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when PRFX files with the SEC.

Where the numbers come from

Financial figures are the values PRF Technologies Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.